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Summary 
The human low affinity receptors for the Fc domain ofimmunoglobulin G, Fc~/RIII, are en- 
coded by two genes (IliA and IIIB) which share >95% sequence identity in both coding and 
flanking sequences. Despite this extraordinary sequence conservation, IliA is expressed in natu- 
ral killer (NK)  cells and macrophages and is absent in neutrophils, whereas IIIB is expressed 
only in neutrophils. To determine the molecular basis for this differential expression, we have 
generated transgenic mice using the genomic sequences of IliA and IIIB. IliA and IIIB trans- 
genic mice show faithful reconstitution of this human pattern of cell type specificity. To deter- 
mine  the  cis  acting  sequence elements that  confer this  specificity, we  constructed chimeric 
genes in which 5.8 kb of 5' sequences of the IIIB gene has been replaced with a homologous 
region from the  IliA gene, and conversely, IliA 5'  sequences have been substituted for the 
analogous region of the IIIB gene. Promoter swap transgenic mice that carry IliA 5' flanking 
sequences express Fc~/tklII in macrophages and NK cells.  In contrast, promoter swap  trans- 
genic mice that contain 11113 5'  sequences express Fc~/RIII in neutrophils only. These studies 
define the elements conferring the cell type-specific expression of the human Fc~/RIII genes 
within the 5' flanking sequences and first intron of the human FcyRIIIA and Fc~RIIIB genes. 
R 
eceptors for the Fc domain oflgG, Fc'yRs, are a fam- 
ily of oligomeric cell surface glycoproteins expressed 
on effector and lymphoid cells that mediate a variety of ac- 
tivation and inhibitory responses to antigen-antibody com- 
plexes. Three classes of Fc~/Rs have been defined based on 
their  different molecular  mass,  affinity for  IgG,  and  ge- 
nomic structures: the high affinity Fc~/RI, and the low af- 
finity Fc~/RII and Fc~/RIII (1, 2). In humans, Fo/RIII ex- 
ists in two alternative forms. FcyRIIIA is a heteromultimeric 
complex composed ofa ligand-binding ot chain and dimeric ~/ 
or ~ chains (3-5). The c~ chain, encoded by the Fc~/RIIIA 
gene, is a type I  transmembrane protein that contains the 
extracellular ligand-binding domain and a distinct cytoplas- 
mic domain (6). The ~/and { chains are required for assem- 
bly and signal transduction of the receptor complex (5). In 
contrast, Fc~/RIIIB is a monomeric protein anchored to the 
outer leaf of the plasma membrane by a glycosyl phosphati- 
dyl inositol moiety (7, 8). The ot chains oflIIA and IIIB are 
>95% identical, conferring indistiguishable ligand binding 
properties on their respective receptors. The appearance of 
these two isoforms is the result of a small number of single- 
nucleotide substitutions in the two genes coding for the ot 
chains  of FcyRIIIA and  Fc~/RIIIB  (9).  Remarkably,  de- 
spite  extensive sequence identity extending into  flanking 
sequences and introns, Fc~/RIIIA is expressed on NK cells 
and  macrophages,  where  it mediates  antibody-dependent 
cellular  cytotoxicity (ADCC)  and  phagocytosis,  whereas 
Fc~/RIIIB is uniquely expressed on neutrophils, where it 
functions primarily as  a  sink for immune  complexes and 
cannot mediate an activation signal in isolation (10). 
As a first step toward understanding the molecular basis 
for the differential expression of human Fc~tRIII genes, we 
have generated transgenic mice expressing human Fc~/RIIIA 
and Fc~/RIIIB using the intact genomic clones. In addition, 
promoter swap  transgenics  were  generated in  which  the 
putative  regulatory  sequences  have  been  exchanged:  se- 
quences derived from the  FcyRIIIA gene 5'  flanking re- 
gion and first intron have been ligated in place of  the corre- 
sponding sequences of the FcyRIIIB gene, and conversely, 
the analogous regions of Fc'yRIIIA have been substituted 
for similar sequences of  the Fc~/RIIIB gene. Comparison of 
the  Fc~/RIII  expression  on  NK  cells,  macrophages,  and 
neutrophils among these four transgenic lines  shows  that 
the  cis  elements conferring the  cell-specific expression of 
the human FcyKIII locate on the 5' flanking sequence and 
first intron of these genes. 
Materials and Methods 
Transgene Constructs.  Genomic clones encoding  human  FcT- 
RIIIA and Fc~/KIIIB (c9158 and c7733, respectively) were iso- 
lated as previously described (9,  11). The NotI-SalI restriction 
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Fc'),RIIIA gene including the signal sequence and EC1 exons and 
the 13-kb SalI-NotI restriction fragment containing the EC2, trans- 
membrane/cytoplasmic (TM/CYT), and 3' UT sequences of the 
FcTIIIB  gene  were  isolated  by  gel  purification,  ligated,  and 
cloned into the NotI site of cosmid vector pWE15. This yielded 
promoter  swap  construct PS19.  Similarly, promoter  swap  con- 
struct PS28 was obtained by ligating three DNA fragments: the 
19.2-kb NotI-SalI restriction fragment of IIIB including the  5' 
flanking sequences,  the  5.8-kb  SalI-EcoRI fragment from  IIIA 
containing EC1,  EC2,  TM/CYT,  and  3' UT  exons,  and  the 
5-kb EcoRI-NotI  of IIIB containing the  3' flanking sequences 
(see Fig. 1). 
Preparation of DNA Fragments  for Microinjection.  Large-scale  plas- 
mid preparations of transgene constructs were performed accord- 
ing to  Sambrook  et  al.  (12).  All four  constructs were  digested 
with NotI  to  release  the  inserts from vector sequences. Digests 
were fractionated by electrophoresis through 1% agarose gel. The 
inserts were isolated by excision of a gel slice and electroelution 
of the DNA fragment into 0.5￿  Tris-borate-EDTA buffer, fol- 
lowed by CsC1 density gradient centrifugation and ethanol pre- 
cipitation.  DNA  pellets  were  washed  in  70%  ethanol,  resus- 
pended in deionized H20, and diluted to a concentration of 1-2 
Ixg/ml with 1 ￿  injection buffer (13). 
Transgenic Mice.  The transgene constructs were microinjected 
into fertilized eggs from (C57B1/6  ￿  CBA/CA) fl matings, and 
the injected eggs were transferred to pseudopregnant female CD-1 
mice (Charles River Laboratories, Wilmington, MA) for develop- 
ment to term. Transgenic founders were identified by Southern 
blot hybridization of BamHI-digested tail DNA to a 32p-labeled 
annealed oligo spanning the transmembrane and cytoplasmic do- 
main  (nucleotides 642-732),  which  is  conserved between  IIIA 
and IIIB. 
Flow Cytometry Analysis.  Single-cell  suspensions  from  bone 
marrow, spleen, and peritoneal cavity were prepared as described 
below. Aliquots of 106 cells were stained for 30 rain at 4~  in 
a  100-p.1 vol with combination of the following antibodies (1 p.g/ 
ml): FITC-anti-human CD16 (3G8 F(ab2)'; Medarex, Inc., West 
Lebanon, NH); PE-anti-mouse granulocyte (RJ36-8C1; PharMin- 
gen, San Diego,  CA),  and anti-mouse Mac-1  (M1/70;  Boeh- 
ringer Mannhein Corp., Indianapolis, IN). Cells were washed twice 
in PBS  containing 1% BSA after  each  incubation and fixed in 
PBS and 1% formaldehyde. Fluorescence intensity was measured 
using a  FACScan  |  (Becton Dickinson &  Co.,  Mountain View, 
CA). Dead cells were eliminated from the analysis on the basis of 
forward and sideways light scatter. 
Cell Preparation.  Mice were injected intraperitoneally with 1 ml 
of 5% thioglycollate, and peritoneal cells were harvested 3 d later. 
The cells were suspended in RPMI 1640 supplemented with 10% 
heat-inactivated FCS and plated in 100 ￿  15-mm dishes (Falcon 
Labware, Becton, Dickinson & Co., Oxnard, CA) and incubated 
for 6 h at 37~  in 95% air, 5% CO2. Nonadherent cells were re- 
moved by  rinsing the  monolayers with  PBS,  and  the  purified 
macrophages were subjected to the flow cytometry analysis. 
Bone marrow cells were flushed out of the femurs of mice us- 
ing a  23-gauge  needle,  resuspended,  and then washed  in PBS. 
The erythrocytes were lysed by NH4C1 buffer (160 mM NH4CI  , 
17  mM Tris-C1, pH  7.4),  and the  remaining cells were  centri- 
fuged and washed with PBS. The bone marrow-derived neutro- 
phils were then used for the FACS  |  analysis. 
NK cells  were prepared  as described previously (14).  Briefly, 
spleens were  removed  aseptically, crushed,  and resuspended in 
NK medium consisting of RPMI 1640 supplemented with 0.1 mM 
nonessential amino acids,  1 mM sodium pyruvate, 50 M  2-ME, 
100 U/rni penicillin, 100 I~g/ml streptomycin, 2 mM glutamine, 
and  10%  heat-inactivated FCS  (HyClone  Laboratories,  Logan, 
UT). The erythrocytes were lysed by NH4C1 buffer, and the re- 
maining cells were centrifuged and then passed through a nylon 
wool column. The  nylon-passed cells  were  resuspended at 5  ￿ 
10  6  cells/ml  and  cultured  in  NK  medium  supplemented with 
1,000  U/ml  recombinant  IL-2  (GIBCO  BRL,  Gaithersburg, 
MD)  and  1  I~g/ml  indomethacin  (Sigma  Chemical  Co.,  St. 
Louis, MO). Fresh media were added at 1:1 vol every 3--4 d. Af- 
ter 7-10 d  of culture, NK cells were harvested and used for the 
FACS  |  analysis. 
Results and Discussion 
Design of Promoter Swap Transgenic Constructs.  To  deter- 
mine which sequences are responsible for the cell type--spe- 
cific expression of human FcTRIII, two promoter swap con- 
structs were  generated.  As shown in Fig.  1,  PS19  contains 
IliA 5' flanking sequences and first intron, and most of the 
IIIB coding and 3 ' untranscribed regions. Our first attempt 
to  construct a  5'IIIB-IIIA3' chimeric gene by ligating the 
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Figure  1.  Maps of the  human Fc'yRlll and pro- 
moter swap transgene constructs.  Top four lines are 
physical maps of the transgene constructs with restric- 
tion sites designated as follows: NotI (N), HindlIl (H), 
EcoRI (E), BamHI (B), and SalI (S). The open boxes 
represent the IliA sequences, and the closed boxes rep- 
resent the IIIB sequences. The intron-exon organiza- 
tion is shown at the bottom. Coding regions are indi- 
cated  by  filled  rectangles,  untranscribed  regions  by 
open rectangles. 5UT, 5' untranslated region; $1, first 
signal exon; $2, second signal exon; ECI, first extra- 
cellular exon; EC2, second extracellular exon; TM/C, 
transmembrane and cytoplasmic domains; 3UT, 3' un- 
translated region; kb, kilobase. The precise 5' borders 
have not been determined,  as indicated by the jagged 
lines. 
1260  Human Fc',/RIII Cell Type Specificity in Mice Figure  2.  Southern blot  analysis of 
the  genomic DNA  from  transgenic 
mice.  Tail DNA  was  digested  with 
BamHl,  electrophoresed,  transferred, 
and blotted with human Fc~tklIl TM/ 
C  probe. The  hybridizing bands are 
~18  kb for IliA and 4.8 kb for IIIB, 
PS19, and PS28. 
IIIB 5' flanking sequence of the NotI-SalI fragment to the 
IliA SalI-NotI fragment was  not successful,  since  the  re- 
sulting insert  could not be  stably propagated  in Escherichia 
coli. We therefore generated the PS28 construct by ligating 
three  DNA  fragments,  creating  a  mosaic  gene  that  con- 
tained  the  IIIB 5' flanking sequences,  the  IliA coding re- 
gions,  and  IIIB 3'  untranslated  regions.  These  two  pro- 
moter swap  constructs  were  confirmed by TaqI  digestion 
and hybridization with  exon-specific probes for the  signal 
sequence  and  3' UT,  which distinguish  between  the  IliA 
and IlIB sequences,  as previously described (9 and data not 
shown). 
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Figure  3.  Flow cytometry analysis of the human Fc~tklII expression 
on macrophages. Thioglycollate-elicited  macrophages were stained with 
3G8 and macrophage marker Mac-1. 
C D 16IF ITC 
Figure  4.  Flow cytometry analysis of human Fc~R.III expression on 
neutrophils. Bone marrow cells were flushed out of the femurs of mice 
and stained with 3G8 and granulocyte  marker Gr-1/RB6. 
Generation of Transgenic Mice.  Each  of  the  four  trans- 
gene  constructs was microinjected  into  fertilized  eggs de- 
rived  from  mating  between  (C57B1/6J  ￿  CBA/CA)  fl 
mice.  Founder mice were identified by hybridizing South- 
ern  blots  of BamHl-digested  tail  DNA  to  a  radiolabeled 
Fc~/RIII TM/C  probe.  A  representative  pattern  of restric- 
tion fragment is shown in Fig. 2. Hybridizing fragments are 
~18 kb for IliA and ~4.8 kb for IIIB, PS19, and PS28. In- 
jection  of IliA  and  PS19  constructs  yielded  two  and  six 
founders,  respectively.  Five founder mice were  generated 
with the PS28 transgene, and three of them bred. Only one 
founder was produced with the IIIB transgene.  The gener- 
ated transgenic mice contained between 5 and 50 copies of 
the  transgenes.  Human Fc~/RIII expression  was  examined 
in all lines, and all lines carrying a particular transgene con- 
struct exhibited qualitatively similar patterns of human Fc~/- 
Rill  expression.  Representative  data  from  the  following 
lines are presented below: IliA, No.  1156; IIIB, No.  1373; 
PS19, No. 4278; PS28, No. 4037. Each of these lines con- 
tained between  10 and 30 copies of the injected transgene 
(Fig. 2 and data not shown). 
Expression  of Human  Fc'yRIIIA  on  Macrophages and  NK 
Cells and IIIB on Neutrophils of Transgenic  Mice.  To  determine 
the  surface  expression  pattern  of human  Fc',/RIII,  mac- 
rophages, neutrophils, and lymphocytes were harvested and 
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Figure  5.  Flow  cytometry analysis of human Fo/RIII expression on 
NK cells. NK cells were prepared as described in Materials and Methods 
and were stained with 3G8. Nonspecific  staining was assessed by using an 
isotype-matcbed negative control, mouse anti-human CD64 mAb 32.2 
(black line). 
examined by FACS  |  analysis.  Thioglycollate-elicited peri- 
toneal  macrophages  were  stained  with  a  panel  of macro- 
phage  makers,  including  Mac-1  and  F4/80,  and  were 
counterstained  with  mAb 3G8,  which  detects both of the 
human  Fo/I<III genes  ix  chains  but  not  the  endogenous 
mouse  FcyP,  III ix  chain.  As seen  in  Fig.  3,  macrophages 
derived  from  the  IIIA-transgenic mice  were  positive  for 
both Mac-1  and 3G8.  Similar  results were obtained using 
F4/80  (data  not  shown).  PS19-transgenic  mice  that  carry 
the 5' flanking sequences and first intron of the  IliA gene 
similarly expressed a double-positive population of Mac-l/ 
3G8 macrophages.  In contrast,  macrophages isolated from 
either IIIB- or PS28-transgenic mice were not stained with 
3G8, yet retained their Mac-1 staining. 
Bone marrow-derived neutrophils were characterized by 
flow cytometry using 3G8 and a granulocyte marker, Gr-1. 
As shown in Fig. 4, neutrophils from IIIB- and PS28-trans- 
genic mice were positive for both 3G8 and Gr-1, whereas 
the  macrophages from these mice were negative  for 3G8. 
In  contrast,  neutrophils  from  IliA-  and  PS19-transgenic 
mice as well  as nontransgenic  littermates  were not stained 
with  3G8,  yet  were  positive  for the  marker  Gr-1.  Mac- 
rophages from nontransgenic littermates of all lines showed 
no detectable 3G8 staining (data not shown). 
Similarly, NK cells prepared from IL-2-activated spleno- 
cytes were positive  for 3G8  staining  on NK  cells  derived 
from IliA- and PS19-transgenic  mice,  as shown in Fig.  5. 
3G8 staining was not detected on splenic T  or B  cells.  No 
detectable 3G8 staining was found on NK cells from IIIB- 
and PS28-transgenic mice. These studies localized the mac- 
rophage/NK cell restricting  element  to a  5.8-kb fragment 
of the IliA gene and a neutrophil-specific element to a 19- 
kb region included in the 5' flanking sequences of the IIIB 
gene. Thus, despite the fact that the mouse expresses a sin- 
gle  Fc~/P, III  gene  in  neutrophils,  macrophages,  and  NK 
cells,  routine  cells  retained  the  ability  to  distinguish  be- 
tween these human sequences that drive cell type specificity. 
Functional  studies  have  suggested  that  IliA delivers  an 
activation signal upon cross-linking by intmune complexes, 
whereas  IlIB occupancy does not result in cellular activa- 
tion in the absence of a costimulatory signal from another 
Fc receptor. Preliminary studies using these transgenic mice 
has confirmed these in vitro observations (Weiner, A., un- 
published observations) and will allow for a detailed exami- 
nation of the role oflIIB in vivo. Finally, the identification 
ofa neutrophil-specific DNA element will facilitate the tar- 
getting  of gene  expression  to  this  important  effector cell 
population and clarify the role of these cells in the inflam- 
matory response. 
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